ACC 2006

Pexelizumab Reduces Mortality in High Risk Coronary Artery By-Pass Patients

March 14, 2006 ⋅ Post a comment
Peter Smith
Peter Smith, Duke University Medical Center, Durham, NC
Late Breaking Clinical Trials, ACC Atlanta 2006, Sunday 12th March 2006
The drug pexelizumab, targeting inflammation, reduced the risk of death among patients about to have coronary artery by-pass grafting in the PRIMOCABG-II study. Peter Smith of Duke University told the ACC about his group’s findings.

Similar Interviews

  • Gene Study Identifies Heart Disease Risk

    • Nilesh Samani REFERENCE: N Engl J Med 2007; 357: 443-53 NILESH SAMANI, University of Leicester UK Previously

  • Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results

    • Philip Barter Gordon Tomaselli REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions,

  • Eicosapentaenoic Acid: Prevention of Coronary Artery Disease

    • A 20 000-person study of eicosapentaenoic acid supplements gave solid scientific support for EPA use to prevent cardiovascular events among

    Post a comment

    Health For All 30 Years After Alma Ata? Mental Health And War»
    AliaIbrahim Zai, Egbert Sondorp, Gill Walt, Lucy Gilson, Ravi Narayan, Richard Horton, Vikram Patel, Willem Van De Put
    Two important symposia have been held in London to discuss healthcare issues posing significant dilemmas to world leaders in the 21st Century. "The Future of Primary Health Care" was attended by public health experts from around the Globe to assess the best options for improving primary health care in the future. It was held on the 30th anniversary of the Alma Ata Declaration made in 1977 which was intended as a blueprint for health provision and identified primary health care as the means through which the global goal of "Health for All" could be achieved. The second meeting, on "Mental Health in Fragile States", was held to raise the profile of mental health care in zones where conflict has taken place or is still happening. Analyses of the key issues and how to deal with them effectively were discussed by top experts from the London School of Hygiene and Tropical Medicine and associated organisations. Peter Goodwin attended both meetings and talked with some of the key speakers.
    LSHTM Audio News: British Association Special Edition»
    Astrid Fletcher, Jo Lines, Sari Kovats, Colin Sutherland, Michel Coleman
    Peter Goodwin hears from London School of Hygiene and Tropical Medicine experts speaking at the annual science festival of the British Association for the Advancement of Science held in Liverpool, September 6-10, 2008, and from recent scientific publications on: the health impact of global warming, a tropical virus reaching temperate zones, inequalities in cancer outcomes, how eating oily fish can save your eyesight, and free internet publishing scientific journals.
    Subscribe to Audio Medica Podcast